President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...

High inventories will weigh on eurozone GDP growth in the first quarter, though the downward impact on goods inflation is ...

The 2022 Inflation Reduction Act (IRA) has introduced significant challenges ... the IRA has certainly influenced a downstream negative impact to their business. But with every challenge there ...

New executive orders could halt promised funding and stop infrastructure and environmental projects that are already underway ...

Welcome to The Hill’s Business & Economy newsletter {beacon} Business & Economy Business & Economy   The Big Story ...

Rising pharmaceutical costs and skimpy insurance coverage can mean larger medication bills for US consumers. But clinicians ...

The Union Budget 2025-26, to be presented on February 1, is expected to prioritise fiscal consolidation while addressing the ...

Filed by Enterprise Bancorp, Inc.pursuant to Rule 425 under the Securities Act of 1933and deemed filed pursuant to Rule ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

First Solar investors likely aren't celebrating Trump's return to the White House. FSLR has taken a 45% decline since June ...

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved ...

The 2025 guidance assumes "stable policy environment." Strong volumes and pricing helped boost GM earnings well past views.